Top Markets
#1 Threshold Network Threshold Network +62.22%
#2 TENDIES TENDIES +59.67%
#3 Cash Cat Cash Cat +21.23%
#4 OSK OSK +15.93%
#5 Magma Finance Magma Finance +13.45%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Kite Kite +11.97%
#8 Maple Finance Maple Finance +11.45%
#9 Falcon Finance Falcon Finance +11.18%
#10 Asteroid Shiba Asteroid Shiba +9.44%
Coin of the day
Threshold Network Threshold Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rangering i aksjer #17261
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Aksjekurs
$0.8502
Sist synkronisert: 2026-09-01
Markedsverdi
$250.47M
Endring (1 dag)
-10.96%
Endring (1 år)
-17.46%
Land
US
Handel Invivyd, Inc. (IVVD)

Kategori

Healthcare
Inntekter for Invivyd, Inc. (IVVD)
Inntekter i 2026 TTM: 0
Ifølge Invivyd, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Invivyd, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH